Xiuquan Ma

7PUBLICATIONS
76CO-AUTHORS
AutoimmunityCardiovascular medicine and haematology not elsewhere classifiedMolecular targetsProteins and peptidesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2026
A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease.

|Jul 09, 2025
NLRP3 inflammasome-driven hemophagocytic lymphohistiocytosis occurs independent of IL-1β and IL-18 and is targetable by BET inhibitors.

Farzaneh Shojaee, Esmaeel Azadian, Min Xian Wong

|Feb 21, 2025
Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer.

Xue Yang, Xiuquan Ma, Tianyue Zhao

|Jun 19, 2023
Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling.

Michael J Roy, Minglyanna G Surudoi, Ashleigh Kropp

|Jan 24, 2023
The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer.

Xue Yang, Miguel I Cruz, Elizabeth V Nguyen

|Feb 22, 2022
Distinct PEAK3 interactors and outputs expand the signaling potential of the PEAK pseudokinase family.

Jianmei Hou, Elizabeth V Nguyen, Minglyanna Surudoi

Pageof 2

Frequent Collaborators

4 joint publications

Roger J Daly

2 joint publications

Kimberley C Clark

2 joint publications

Terry C C Lim Kam Sian

2 joint publications

Minglyanna Surudoi